Article

The Lambda variant of SARS-CoV-2 has a better chance than the Delta variant to escape vaccines

2021-08-26

Abstract excerpt

<h4>Summary</h4> The newly emerging variants of SARS-CoV-2 from India (Delta variant) and South America (Lambda variant) have led to a higher infection rate of either vaccinated or unvaccinated people. We found that sera from Pfizer-BioNTech vaccine remain high reactivity toward the receptor binding domain (RBD) of Delta variant while it drops dramatically toward that of Lambda variant. Interestingly, the overall...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: accd4ced-52e5-5210-8c1b-0d386f2446be
DOI: 10.1101/2021.08.25.457692

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The Lambda variant of SARS-CoV-2 has a better chance than the Delta variant to escape vaccinesDOI 10.1101/2021.08.25.457692Read

Current Review of Delta Variant of SARS-CoV-2Semantic proximity Read

The Receptor Binding Domain of SARS-CoV-2 Lambda Variant Has a Better Chance Than the Delta Variant in Evading BNT162b2 COVID-19 mRNA Vaccine-Induced Humoral Immunity.Semantic proximity Read

Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion.Semantic proximity Read

Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions.Semantic proximity Read

Structural basis for SARS-CoV-2 Delta variant recognition of ACE2 receptor and broadly neutralizing antibodiesSemantic proximity Read

A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75Semantic proximity Read

Structure-Function Analysis of Resistance to Bamlanivimab by SARS-CoV-2 Variants Kappa, Delta, and Lambda.Semantic proximity Read

The Influence of New SARS-CoV-2 Variant Omicron (B.1.1.529) on Vaccine Efficacy, its Correlation to Delta Variants: A Computational ApproachSemantic proximity Read

SARS-CoV-2 Delta derivatives impact on neutralization of Covishield recipient seraSemantic proximity Read

In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion.Semantic proximity Read

Impact of B.1.617 and RBD SARS-CoV-2 Variants on Vaccine Efficacy: An In-silico ApproachSemantic proximity Read

Molecular Aspects Concerning the Use of the SARS-CoV‑2 Receptor Binding Domain as a Target for Preventive VaccinesSemantic proximity Read